論文 2019年

  • Hagino H, Sakai A, Ikeda S, Imanishi Y, Tsurukami H, Nakajo S, Miyakoshi N. Effectiveness of monthly intravenous ibandronate on the low responders to oral bisphosphonate: the MOVEMENT study. J. Bone Miner. Metab. 2019 in press
  • Hara K, Mizuguchi S, Okada S, Izumi N, Tsukioka T, Komatsu H, Ohsawa M, Inaba M, Shibata T,Nishiyama N. Intensity of SLX predicts distance of tumor spread through alveolar spaces in stage I lungadenocarcinoma. Thorac Cancer 2019;10:832-838
  • Hayashi M, Morioka T, Hatamori M, Kakutani Y, Yamazaki Y, Kurajoh M, Motoyama K, Mori K,Fukumoto S, Shioi A, Shoji T, Emoto M, Inaba M. Plasma omentin levels are associated with vascularendothelial function in patients with type 2 diabetes at elevated cardiovascular risk. Diabetes Res Clin Pract 2019;148:160-168
  • Kurajoh M, Fukumoto S, Emoto M, Murase T, Nakamura T, Ishihara T, Go H, Yamamoto K, Nakatani S,Tsuda A, Yamada S, Morioka T, Mori K, Imanishi Y, Inaba M. Independent association of plasma xanthineoxidoreductase activity with serum uric acid level based on stable isotope-labeled xanthine and liquid chromatography/triple quadrupole mass spectrometry: MedCity21 health examination registry. Clin Chem Lab Med 2019 (in press)
  • Kurajoh M, Inaba M, Motoyama K, Kuriyama N, Ozaki E, Koyama T, Yamada S, Morioka T, Imanishi Y,Emoto M. Inverse association of plasma leptin with cortical thickness at distal radius determined with aquantitative ultrasound device in patients with type 2 diabetes mellitus. J Diabetes Investig 2019 (in press)
  • Kurajoh M, Inaba M, Nagata Y, Yamada S, Imanishi Y, Emoto M. Association of cystatin C- and creatininebased eGFR with osteoporotic fracture in Japanese postmenopausal women with osteoporosis: sarcopenia as risk for fracture. J Bone Miner Metab 2019;37:282-291
  • Kurajoh M, Yamasaki A, Nagasaki T, Nagata Y, Yamada S, Imanishi Y, Emoto M, Takahashi K, Yamamoto K, Shintani A, Inaba M. Thyroid blood flow in inferior thyroid artery as predictor for increase in levothyroxine dosage during pregnancy in women with Hashimoto's thyroiditis - a retrospective study. BMC Pregnancy Childbirth 2019;19:232
  • Miki Y, Morioka T, Shioi A, Fujimoto K, Sakura T, Uedono H, Kakutani Y, Ochi A, Mori K, Shoji T, Emoto M, Inaba M. Oncostatin M induces C2C12 myotube atrophy by modulating muscle differentiation and degradation. Biochem Biophys Res Commun 2019;516:951-956
  • Miyabe M, Kurajoh M, Mori K, Okuno S, Okada S, Emoto M, Tsujimoto Y, Inaba M. Superiority of glycated albumin over glycated hemoglobin as indicator of glycemic control and predictor of all-cause mortality in patients with type 2 diabetes mellitus receiving peritoneal dialysis. Ann Clin Biochem 2019:4563219873688
  • Miyaoka D, Imanishi Y, Ohara M, Hayashi N, Nagata Y, Yamada S, Mori K, Emoto M, Inaba M. Impaired residual renal function predicts denosumab-induced serum calcium decrement as well as increment of bone mineral density in non-severe renal insufficiency. Osteoporos Int 2019;30:241-249
  • Miyaoka D, Inaba M, Imanishi Y, Hayashi N, Ohara M, Nagata Y, Kurajoh M, Yamada S, Mori K, Emoto M. Denosumab Improves Glomerular Filtration Rate in Osteoporotic Patients With Normal Kidney Function by Lowering Serum Phosphorus. J Bone Miner Res 2019 (in press)
  • Miyawaki J, Okuno S, Mori K, Nishio E, Norimine K, Kurajoh M, Yamakawa T, Shoji S, Inaba M. Inverse association of fat mass, but not lean mass, with glycated albumin in hemodialysis patients with or without diabetes mellitus. Ren Fail 2019;41:808-813
  • Miyoshi A, Koyama S, Sasagawa-Monden M, Kadoya M, Konishi K, Shoji T, Inaba M, Yamamoto Y, Koyama H. JNK and ATF4 as two important platforms for tumor necrosis factor-alpha-stimulated shedding of receptor for advanced glycation end products. FASEB J 2019;33:3575-3589
  • Mori K, Emoto M, Abe M, Inaba M. Visualization of Blood Glucose Fluctuations Using Continuous Glucose Monitoring in Patients Undergoing Hemodialysis. J Diabetes Sci Technol 2019;13:413-414 15. Mori K, Nishide K, Okuno S, Shoji T, Emoto M, Tsuda A, Nakatani S, Imanishi Y, Ishimura E, Yamakawa T, Shoji S, Inaba M. Impact of diabetes on sarcopenia and mortality in patients undergoing hemodialysis. BMC Nephrol 2019;20:105
  • Morita E, Yokoyama H, Imai D, Takeda R, Ota A, Kawai E, Hisada T, Emoto M, Suzuki Y, Okazaki K. Aerobic exercise training with brisk walking increases intestinal Bacteroides in healthy elderly women.Nutrients 2019;11:868.
  • Nagata Y, Imanishi Y, Ohara M, Maeda-Tateishi T, Miyaoka D, Hayashi N, Kurajoh M, Emoto M, Inaba M. Attenuated Dentin Matrix Protein 1 Enhances Fibroblast Growth Factor 23 in Calvaria in a Primary Hyperparathyroidism Model. Endocrinology 2019;160:1348-1358
  • Nakatani S, Ishimura E, Machiba Y, Nakatani A, Fujimoto K, Uedono H, Okute Y, Tsuda A, Mori K, Emoto M, Inaba M. Novel increasing dose regimen of tolvaptan for autosomal dominant polycystic kidney disease in patient with low tolerability. Nephrology (Carlton) 2018;23:798-799
  • Nishizawa Y, Miura M, Ichimura S, Inaba M, Imanishi Y, Shiraki M, Takada J, Chaki O, Hagino H, Fukunaga M, Fujiwara S, Miki T, Yoshimura N, Ohta H, from the Japan Osteoporosis Society Bone Turnover Marker Investigation C. Executive summary of the Japan Osteoporosis Society Guide for the Use of Bone Turnover Markers in the Diagnosis and Treatment of Osteoporosis (2018 Edition). Clin Chim Acta 2019;498:101-107
  • Okawa N, Kuratsune D, Koizumi J, Mizuno K, Kataoka Y, Kuratsune H. Application of autonomic nervous function evaluation to job stress screening. Heliyon 2019;5:e01194
  • Okuno S, Inaba M, Ishimura E, Nakatani S, Chou H, Shoji S, Yamakawa T. Effects of Long-Term Cinacalcet Administration on Parathyroid Gland in Hemodialysis Patients with Secondary Hyperparathyroidism. Nephron 2019;142:106-113
  • Portale AA, Carpenter TO, Brandi ML, Briot K, Cheong HI, Cohen-Solal M, Crowley R, Jan De Beur S, Eastell R, Imanishi Y, Imel EA, Ing S, Ito N, Javaid M, Kamenicky P, Keen R, Kubota T, Lachmann R, Perwad F, Pitukcheewanont P, Ralston SH, Takeuchi Y, Tanaka H, Weber TJ, Yoo HW, Zhang L, Theodore-Oklota C, Mealiffe M, San Martin J, Insogna K. Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period. Calcif. Tissue Int. 2019;105:271-284.
  • Toi N, Inaba M, Ishimura E, Tsugawa N, Imanishi Y, Emoto M, Hirayama Y, Nakatani S, Saito A, Yamada S. Significance of urinary C-megalin excretion in vitamin D metabolism in pre-dialysis CKD patients. Sci Rep 2019;9:2207
  • Toi N, Inaba M, Kurajoh M, Morioka T, Hayashi N, Hirota T, Miyaoka D, Emoto M, Yamada S. Improvement of glycemic control by treatment for insomnia with suvorexant in type 2 diabetes mellitus. J Clin Transl Endocrinol 2019;15:37-44